GUGGUL-POWER Trademark

Trademark Overview


On Monday, March 27, 2000, a trademark application was filed for GUGGUL-POWER with the United States Patent and Trademark Office. The USPTO has given the GUGGUL-POWER trademark a serial number of 76010560. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, January 4, 2002. This trademark is owned by Twin Laboratories Inc.. The GUGGUL-POWER trademark is filed in the Pharmaceutical Products category with the following description:

vitamins; minerals; dietary supplements; and herbs, herbal extracts, and amino acids for use as dietary supplements; and medications, namely, substances and preparations for use in the treatment of allergies, hay fever, nasal congestion, asthma, shortness of breath, tightness of chest, wheezing, stress, tension, common cold, fatigue, diarrhea, gas pains, abdominal cramps, stomach distress, intestinal distress, bloating, distension, fullness, pressure, water weight gain, swelling, inflammation, fevers, irregularity, constipation, sleep disorders, headaches, motion sickness, nausea, vomiting, low energy, dietary deficiencies, nutritional deficiencies, poor health, blood conditions, circulatory conditions, digestive conditions, premenstrual conditions, menstrual conditions, eye conditions, immune system conditions, metabolic conditions, conditions of the joints, and conditions associated with aging, all of the above featuring guggul
guggul-power

General Information


Serial Number76010560
Word MarkGUGGUL-POWER
Filing DateMonday, March 27, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, January 4, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 10, 2001

Trademark Statements


Goods and Servicesvitamins; minerals; dietary supplements; and herbs, herbal extracts, and amino acids for use as dietary supplements; and medications, namely, substances and preparations for use in the treatment of allergies, hay fever, nasal congestion, asthma, shortness of breath, tightness of chest, wheezing, stress, tension, common cold, fatigue, diarrhea, gas pains, abdominal cramps, stomach distress, intestinal distress, bloating, distension, fullness, pressure, water weight gain, swelling, inflammation, fevers, irregularity, constipation, sleep disorders, headaches, motion sickness, nausea, vomiting, low energy, dietary deficiencies, nutritional deficiencies, poor health, blood conditions, circulatory conditions, digestive conditions, premenstrual conditions, menstrual conditions, eye conditions, immune system conditions, metabolic conditions, conditions of the joints, and conditions associated with aging, all of the above featuring guggul
Pseudo MarkGUGGUL POWER

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 21, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTwin Laboratories Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAmerican Fork, UT 84003

Party NameTwin Laboratories Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAmerican Fork, UT 84003

Trademark Events


Event DateEvent Description
Saturday, June 15, 2002ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 3, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2001PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2001NOTICE OF PUBLICATION
Tuesday, January 2, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 7, 2000EXAMINER'S AMENDMENT MAILED
Tuesday, August 29, 2000ASSIGNED TO EXAMINER